The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes the
coronavirus disease 2019 (COVID-19) with innate and adaptive immune response triggered …

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused the
pandemic of the coronavirus induced disease 2019 (COVID-19) with evolving variants of …

Extracellular vesicles (EVs) are nanoscale vesicles naturally released from cells that are
delimited by a lipid bilayer and cannot replicate (Van Niel et al., 2018). Growing evidence …

Extracellular vesicles of endosomal origin, exosomes, mediate intercellular communication
by transporting substrates with a variety of functions related to tissue homeostasis and …

The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has
triggered a global pandemic, which severely endangers public health. Our and others' works …

Continued emergence of SARS-CoV-2 variants of concern that are capable of escaping
vaccine-induced immunity highlights the urgency of developing new COVID-19 therapeutics …

Writing in PLOS Biology, Ching and colleagues show that ACE2-decorated exosomes are
deployed as natural inhibitory decoys against SARS-CoV-2. High decoy levels correlate with …

The novel strain of coronavirus that appeared in 2019, SARS-CoV-2, is the causative agent
of severe respiratory disease, COVID-19, and the ongoing pandemic. As for SARS-CoV that …

The spread of coronavirus disease 2019 (COVID-19) throughout the world has resulted in
stressful healthcare burdens and global health crises. Developing an effective measure to …

Rationale: Macrophages are the frontline immune cells in response to severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Angiotensin-converting …